Cite
HARVARD Citation
Schwartz, G. et al. (n.d.). 370 A first-in-human phase 1/1b study of receptor tyrosine kinase (RTK) inhibitor, MGCD, in patients with advanced solid tumors. European journal of cancer. pp. S78-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Schwartz, G. et al. (n.d.). 370 A first-in-human phase 1/1b study of receptor tyrosine kinase (RTK) inhibitor, MGCD, in patients with advanced solid tumors. European journal of cancer. pp. S78-. [Online].